[HTML][HTML] Oral anticoagulant therapy in older adults
J Stuby, M Haschke, T Tritschler, D Aujesky - Thrombosis research, 2024 - Elsevier
Patients aged≥ 65 years not only account for the majority of patients with atrial fibrillation
(AF) and venous thromboembolism (VTE), they are also at a higher risk of morbidity …
(AF) and venous thromboembolism (VTE), they are also at a higher risk of morbidity …
[HTML][HTML] Repurposable Drugs for Immunotherapy and Strategies to Find Candidate Drugs
N Sakai, K Kamimura, S Terai - Pharmaceutics, 2023 - mdpi.com
Conventional drug discovery involves significant steps, time, and expenses; therefore, novel
methods for drug discovery remain unmet, particularly for patients with intractable diseases …
methods for drug discovery remain unmet, particularly for patients with intractable diseases …
AVALIAÇÃO DA EFICÁCIA DAS NOVAS TERAPIAS ANTICOAGULANTES ORAIS NA PREVENÇÃO DE EVENTOS RELACIONADOS À FIBRILAÇÃO ATRIAL: UMA …
LMR Bezerra, LF de Holanda Furtado… - … -ISSN 2675-6218, 2024 - recima21.com.br
A fibrilação atrial é uma condição clínica comum associada a um aumento significativo no
risco de eventos cardiovasculares, como o acidente vascular cerebral (AVC). O advento das …
risco de eventos cardiovasculares, como o acidente vascular cerebral (AVC). O advento das …